The luxury skincare market after Q3 2026: value moves toward proof and toward origin. | Photo: Photo: freestockcenter / magnific.com
The luxury skincare market grew where houses build their own science, while the large groups bought their way into natural skincare and the conventional prestige cream stalled. Korea held its lead, Japan slipped, and China arrived as a power of its own.
Eva Winterer
This article is part of the dossier on the luxury beauty market, The Nature of Beauty.
The luxury skincare market spent the third quarter rewarding laboratories and buying land. Puig reported a second straight decline in its own skincare. In September, the Barcelona group agreed to pay €1.2 billion for the half of Isdin it did not already own. The Puig and Esteve families founded the dermatology house together in 1975. In October, The Estée Lauder Companies completed its purchase of Forest Essentials, the Ayurvedic house from New Delhi. The largest groups build the science of skin themselves. Nature, they buy.
In July, Beyond Paris and New York mapped the new powers of the market. It sorted them by three ways of making a cream: the untouched plant, the laboratory, and the conventional formula that borrows a plant for its story. Three quarters of results now show how value moves between them. The laboratory grows fastest, and the houses build it in-house. Natural skincare keeps growing, and the large groups buy it. The conventional cream has stopped growing, and fragrance now carries the groups that once lived on it.
Built in the Lab: Dermatology Leads the Luxury Skincare Market
Skincare sold on clinical proof grew faster than anything else the large houses make, and the gap widened through the year. Galderma, the Swiss dermatology company, grew its dermatological skincare by 17.0, 15.8 and 15.6 percent in the first three quarters, at constant currency. L’Oréal’s Dermatological Beauty division, home to La Roche-Posay and CeraVe, rose 10.2, 11.1 and then 13.9 percent on an adjusted basis. Beiersdorf’s Derma business, behind Eucerin and Aquaphor, grew 10.6 percent in the third quarter.
These are fields the houses built themselves. L’Oréal has owned La Roche-Posay since 1989 and grew it into the core of its fastest division. Amorepacific developed Aestura and Illiyoon in its own laboratories in Seoul. Its revenue rose 11 percent in the third quarter and operating profit 25 percent, with Aestura’s sales in Korea up by more than half.
Natura is the exception. The July map placed the Brazilian house in this field for its clinical work on Amazonian botanicals. Its revenue fell 7.7 percent in the first quarter and 9.1 percent in the second. Its third-quarter results are due on 12 November.
Dermatology Pulled Away From the Classic Cream, Quarter by Quarter
Sales growth of the houses that report skincare separately, quarter by quarter in 2026. The shaded band is the gap between the two, and it widened every quarter. The olive line marks Weleda, which grows from the field and reports once a year.
Q3
13.3
percentage points between the lab and the classic cream
Growth at constant currency, like-for-like or organic, as each company reports it. Galderma: Dermatological Skincare. L’Oréal: Dermatological Beauty, adjusted. Beiersdorf: Derma. LVMH: Perfumes and Cosmetics. Puig: Skincare. Weleda: cosmetics, full year 2025. The gap compares the average of the three dermatology businesses with the average of LVMH and Puig, calculated by The Silent Luxury. Sources: company reports, April to October 2026.
Bought at the Source: Who Owns Natural Luxury Skincare
Natural skincare, where the plant reaches the jar much as it grew, is the field the large groups buy rather than build. Estée Lauder took full ownership of Forest Essentials in October, after 18 years as a partner. Puig has held a majority of Kama Ayurveda since 2022 and owns Loto del Sur in Colombia. Amorepacific owns Tata Harper, whose formulas begin on a farm in Vermont. None of the three groups reports the sales of these houses separately.
The houses that remain independent publish little. Weleda is the exception. The Swiss house grows many of its plants on its own biodynamic land, and its cosmetics sales rose 9.2 percent in 2025, to €401.9 million. In the same year its operating profit fell from €23 million to €9.5 million. Dr. Hauschka, owned by a German foundation, publishes no comparable figures. Smaller houses such as Furtuna Skin in Sicily, Africology in South Africa and Bush Medijina in Australia report nothing at all.
The field grows on its own calendar. Its houses report once a year, and the groups that buy them fold the figures into their own.
Prestige Skincare Stalls: The Conventional Cream After Q3
The conventional prestige cream, a familiar base with a plant in its story, barely grew all year. LVMH's Perfumes & Cosmetics division, home to Dior and Guerlain, moved 0, minus 1 and plus 1 percent on an organic basis. Puig's skincare rose 4.7 percent at constant currency in the first quarter, then fell 0.3 and 0.8 percent. Coty's prestige business shrank 5 percent and then 0.5 percent in the first two quarters. Chanel, Clarins, Sisley, Caudalie and L'Occitane, the privately held houses of this field, publish no quarterly figures.
Where growth survives, it comes from science. Estée Lauder's skincare was flat in the first quarter, rose 7 percent in the second and 4 percent in the third. La Mer, built on a months-long ferment, and The Ordinary carried it, while Clinique declined. The groups have found their growth elsewhere. Estée Lauder's fragrance sales rose 20 percent in the third quarter, and Puig has rebuilt its plan around scent.
The Lab Grew Fastest, Nature Kept Growing, the Classic Cream Stood Still
Three ways of making a cream, three jars. Each fills with the sales growth its houses reported, quarter by quarter in 2026.
Q3
Built in the lab
13.4%average growth in Q3
Galderma 15.6%, L'Oréal Dermatological Beauty 13.9%, Beiersdorf Derma 10.6%. The groups built this science themselves.
Grown in the field
9.2%Weleda cosmetics, full year 2025
The houses of this field report once a year, many as foundations or family firms. The large groups now want them: Forest Essentials belongs to Estée Lauder, Kama Ayurveda to Puig, Tata Harper to Amorepacific.
The conventional cream
0.1%average growth in Q3
LVMH Perfumes & Cosmetics 1%, Puig skincare −0.8%. Fragrance now carries both groups.
Growth at constant currency, like-for-like or organic, as each company reports it. Averages are a simple mean calculated by The Silent Luxury. Weleda reports annually; its jar shows the full year 2025. A full jar stands for 15 percent; a quarter of decline leaves the jar empty. Sources: company reports, April to October 2026.
Korea, Japan and China: New Powers in the Luxury Skincare Market
Korea held its lead through the year. Its cosmetics exports rose 21.5 percent in the first quarter, 27 percent in the first half and 33.6 percent from January to October. Japan, which the July map placed beside Korea, slipped. Shiseido's sales fell 2.7 percent in the first quarter and were roughly flat for the half. Kosé's first-half sales grew 2.7 percent, while its operating profit fell 41.5 percent.
China is the power the July map left out. Chinese brands held 57.4 percent of their home market in 2025, according to the China Association of Fragrance, Flavor and Cosmetic Industries. Proya, the country's largest beauty group, opened a research laboratory in Paris in October. Its serums reach 400 Ulta Beauty stores in the United States this month. Its third-quarter revenue rose 29.8 percent, though recurring profit fell by almost two thirds. Botanee, whose Winona brand treats sensitive skin, grew 5 percent in the first nine months. The makers of biotech ingredients are under pressure. Bloomage, the largest producer of hyaluronic acid, saw its sales fall 17.9 percent over the same period.
What Q4 Will Test: The Luxury Skincare Market Through Winter
The fourth quarter will test the pattern in the season that favors the conventional houses most, when gift sets and holiday counters do their strongest trade. Shiseido reports on 10 November and will show whether Japan recovers. Natura follows on 12 November and will show whether Brazil's decline has run its course. Puig will show whether its own skincare recovers before Isdin passes to it in full early next year. Forest Essentials will show how a global group runs a house whose value lies in a place.
The direction since July is clear. Value moves toward skin science that a house builds itself, and toward natural ingredients that the large groups now prefer to own. For the buyer, the shift rewards two questions at any counter: what has been proven about this cream, and where did it grow?
For anyone who asks what a cream can prove, and where it grew.
Chanel is selling its majority stake in Capsum, the Marseille developer and maker of skincare and make-up, to the Paris private equity firm Motion Equity Partners, and keeps a minority share.
South Korea's beauty exports reached a record $7 billion in the first half of 2026, up 27 percent, while France, still the world's largest exporter, lost ground in the United States.
The third-quarter results of LVMH, Hermès, Kering, Prada, Zegna and L'Oréal point in one direction: luxury now grows through the clients who already belong.
